Business
Autonomix Medical, Inc. Announces Abstract Highlighting Technology and Early Proof-of-Concept Study Results Accepted at the Society of Interventional Radiology (SIR) Annual Scientific Meeting
THE WOODLANDS, TX, March 06, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced its abstract has been accepted for poster presentation at the 2025 Society of Interventional Radiology (“SIR”) Annual Scientific Meeting being held March 29-April 2, 2025 in in Nashville, Tennessee. Deta
About this update from Autonomix Medical, Inc.
[{"type":"image","alt":"Autonomix Medical, Inc.","displaySize":"","headline":null,"caption":"Autonomix Medical, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":174,"url":"https://media.zenfs.com/en/globenewswire.com/5cca67be9740fed2b1f7fe47e0e265b6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/yXZC_k658ygjAcliUe7Yow--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTI0NDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/5cca67be9740fed2b1f7fe47e0e265b6","width":300,"height":174}},"lazy":false},{"type":"text","content":"THE WOODLANDS, TX, March 06, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced its abstract has been accepted for poster presentation at the 2025 Society of Interventional Radiology (“SIR”) Annual Scientific Meeting being held March 29-April 2, 2025 in in Nashville, Tennessee.","length":495,"tagName":"p"},{"type":"text","content":"Details of the accepted abstract are as follows:","length":48,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Title: Pain Mitigation in Pancreatic Adenocarcinoma: An Interim Analysis of Neurolysis via Transvascular RF Energy-Based Ablation","length":134,"tagName":"p"}]},{"val":[{"type":"text","content":"Presenter: Bela Kis, MD, PhD, FSIR, Chief of Interventional Radiology, Moffitt Cancer Center","length":92,"tagName":"p"}]},{"val":[{"type":"text","content":"Presentation Date and Time: Monday, March 31, 12:10 PM – 1:10 PM CT","length":67,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":293,"olType":false},{"type":"text","content":"SIR is a nonprofit, professional medical society representing more than 8,000 practicing interventional radiology physicians, trainees, students, scientists and clinical associates, dedicated to improving patient care through the limitless potential of image-guided therapies. SIR’s members work in a variety of settings and at different professional levels—from medical students and residents to university faculty and private practice physicians. The 2025 SIR Annual Scientific Meeting will gather interventional radiologists to explore emerging methodologies; discover groundbreaking research; exp...